Back Login for AI Analysis

    HALO (STOCKS)

    Halozyme Therapeutics, Inc.

    $121.370000
    -0.140000 (-0.12%)
    Prev close: $121.510000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Helen I. Torley
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $13,828.60M
    Employees
    350
    P/E (TTM)
    34.90
    P/B (TTM)
    92.81
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    3
    Strong Buy
    10
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    		 $2.28 $1.87 +0.4073 +21.75%
    Mar 2026 (Q1)
    		 $1.60 $1.56 +0.0394 +2.52%
    Dec 2025 (Q4)
    		 $-0.24 $2.24 -2.4820 -110.70%
    Sep 2025 (Q3)
    		 $1.72 $1.66 +0.0591 +3.56%